Table 1. Baseline demographic characteristics of the groups.

	Prolotherapy group (n=26)		Control group (n=24)
	n	Mean±SD	n	Mean±SD	p
Age (years)		45.1±6.7		46.3±7.6	0,539
Sex					0,623
Female	21		19
Male	5		6
Time of symptoms (month)		32.8±23.9		34.3±23.3	0,825
Side					0,616
Right	18		15
Left	8		9
Visual Analog Scale (Baseline)		6.9±1.5		6.7±1.44	0,600
AOFAS (Baseline)		55.0±15.5		57.4±14.4	0,683
Foot Function Index (Baseline)		57.7±13.6		56.9±12.7	0,834
SD: Standard deviation; AOFAS: American Orthopedic Foot and Ankle Society Clinical Rating System.